197 related articles for article (PubMed ID: 18097613)
1. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
[TBL] [Abstract][Full Text] [Related]
2. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
3. Prevention of tissue injury by ribbon antisense to TGF-beta1 in the kidney.
Choi YK; Moon IJ; Jung HK; Jang BC; Seo SI; Park JG
Int J Mol Med; 2005 Mar; 15(3):391-9. PubMed ID: 15702227
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
[TBL] [Abstract][Full Text] [Related]
8. Effects of TGF-beta1 Ribbon Antisense on CCl(4)-induced Liver Fibrosis.
Kyung-Oh D
Korean J Physiol Pharmacol; 2008 Feb; 12(1):1-6. PubMed ID: 20157387
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
11. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
Yang HX; Yi YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M
Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157
[TBL] [Abstract][Full Text] [Related]
13. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
Li Q; Zhou X; Yu J; Qian W; Xu KS
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
[TBL] [Abstract][Full Text] [Related]
14. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ
Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of type I procollagen C-proteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis.
Ogata I; Auster AS; Matsui A; Greenwel P; Geerts A; D'Amico T; Fujiwara K; Kessler E; Rojkind M
Hepatology; 1997 Sep; 26(3):611-7. PubMed ID: 9303490
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
Choi HK; Pokharel YR; Lim SC; Han HK; Ryu CS; Kim SK; Kwak MK; Kang KW
Toxicol Appl Pharmacol; 2009 Nov; 240(3):377-84. PubMed ID: 19647758
[TBL] [Abstract][Full Text] [Related]
17. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK
Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.
Wolff RA; Malinowski RL; Heaton NS; Hullett DA; Hoch JR
J Vasc Surg; 2006 May; 43(5):1028-36. PubMed ID: 16678700
[TBL] [Abstract][Full Text] [Related]
19. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
[TBL] [Abstract][Full Text] [Related]
20. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
